Jake R. Morgan, PhD
Research Assistant Professor
Boston University School of Public Health
Dept of Health Law, Policy & Management

PhD, Boston University
MS, Montana State University

I am a health services researcher dedicated to using real world data to predict individual- and population-level health outcomes and inform health policy. My postdoctoral research experience at a large safety net hospital has exposed me to the challenges to, and the urgency of, addressing the opioid crisis, and I productively research questions of addiction and infectious disease by leveraging real world data, simulation modeling, and innovative methodology. I am most interested in answering important scientific questions with immediate policy and practice relevance; as such, I work closely with the Massachusetts Department of Public Health and the NIDA-sponsored Center for Health Economics of Interventions for Substance Use Disorder, HCV, and HIV (CHERISH) and stakeholders from policy and research backgrounds on these important questions.

2016 Patient-Centered Outcomes Research Institute (PCORI): Trainee Scholarship
2015 Lee Lusted Prize winner

The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for HCV Trial
01/01/2019 - 12/31/2022 (Subcontract PI)
Denver Health Medical Center NIH NIDA

02/25/2019 - 09/29/2021 (Subcontract PI)
RAND Corporation HHS CDC

Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (CHERISH)
05/01/2019 - 04/30/2020 (Subcontract PI)
Weill Medical College of Cornell University NIH NIDA

Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (CHERISH Supplement)
05/01/2019 - 04/30/2020 (Subcontract PI)
Weill Medical College of Cornell NIH NIDA

Impact of health insurance type and transitions on treatment for opioid use disorder
04/01/2019 - 03/31/2020 (Subcontract PI)
Boston Medical Center Corporation Robert Wood Johnson

Researching Effective Strategies to Prevent Opioid Death (RESPOND)
04/01/2019 - 03/31/2020 (Subcontract PI)
Boston Medical Center Corporation NIH NIDA

Prevention and Rescue Of Fentanyl and Other Opioid Overdoses Using Optimized Naloxone Distribution Strategies (PROFOUND)
05/15/2019 - 02/29/2020 (Subcontract PI)
Weill Medical College of Cornell NIH NIDA

WHO Level of Detection
04/01/2019 - 12/31/2019 (Subcontract PI)
FIND Foundation World Health Org


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Gutkind S, Schackman BR, Morgan JR, Leff JA, Agyemang L, Murphy SM, Akiyama MJ, Norton BL, Litwin AH, Linas BP. Cost-effectiveness of Hepatitis C Virus Treatment Models for People Who Inject Drugs in Opioid Agonist Treatment Programs. Clin Infect Dis. 2020 Mar 17; 70(7):1397-1405.View Related Profiles. PMID: 31095683
  2. Morgan JR, Wang J, Barocas JA, Jaeger JL, Durham NN, Babakhanlou-Chase H, Bharel M, Walley AY, Linas BP. Opioid overdose and inpatient care for substance use disorder care in Massachusetts. J Subst Abuse Treat. 2020 May; 112:42-48.View Related Profiles. PMID: 32199545
  3. Carey K, Morgan JR. Payments for outpatient joint replacement surgery: A comparison of hospital outpatient departments and ambulatory surgery centers. Health Serv Res. 2020 Apr; 55(2):218-223.View Related Profiles. PMID: 31971261
  4. Barocas JA, Morgan JR, Wang J, McLoone D, Wurcel A, Stein MD. Outcomes Associated with Medications for Opioid Use Disorder Among Persons Hospitalized for Infective Endocarditis. Clin Infect Dis. 2020 Jan 21.View Related Profiles. PMID: 31960025
  5. Carey K, Morgan JR, Lin MY, Kain MS, Creevy WR. Patient Outcomes Following Total Joint Replacement Surgery: A Comparison of Hospitals and Ambulatory Surgery Centers. J Arthroplasty. 2020 01; 35(1):7-11.View Related Profiles. PMID: 31526700
  6. Barocas JA, Morgan JR, Fiellin DA, Schackman BR, Eftekhari Yazdi G, Stein MD, Freedberg KA, Linas BP. Cost-effectiveness of integrating buprenorphine-naloxone treatment for opioid use disorder into clinical care for persons with HIV/hepatitis C co-infection who inject opioids. Int J Drug Policy. 2019 10; 72:160-168.View Related Profiles. PMID: 31085063
  7. Morgan JR, Schackman BR, Weinstein ZM, Walley AY, Linas BP. Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort. Drug Alcohol Depend. 2019 07 01; 200:34-39.View Related Profiles. PMID: 31082666
  8. Barlam TF, Morgan JR, Kaplan WA, Outterson K, Pelton SI. Disproportionate Exposure to Antibiotics in Children at Risk for Invasive Pneumococcal Disease: Potential for Emerging Resistance and Opportunity for Antibiotic Stewardship. J Pediatric Infect Dis Soc. 2019 Mar 28; 8(1):63-65.View Related Profiles. PMID: 28992176
  9. Morgan JR, Carey KM, Barlam TF, Christiansen CL, Drainoni ML. Inappropriate Antibiotic Prescribing for Acute Bronchitis in Children and Impact on Subsequent Episodes of Care and Treatment. Pediatr Infect Dis J. 2019 03; 38(3):271-274.View Related Profiles. PMID: 29794648
  10. Murphy SM, Morgan JR, Jeng PJ, Schackman BR. Will converting naloxone to over-the-counter status increase pharmacy sales? Health Serv Res. 2019 08; 54(4):764-772. PMID: 30790269
Showing 10 of 29 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 29 publications over 7 distinct years, with a maximum of 6 publications in 2015 and 2019


Contact for Mentoring:
Morgan's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department